Anthony J. Scalzo

The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer.

Stephen L. Graziano, Rummana Mazid, Nancy Newman et al. · Journal of Clinical Oncology · 1989 · 189 citations

Tumor Biology, Chemotherapy Response, Non-small-cell Lung Cancer +15

Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B.

Michael P. Kosty, Stewart B. Fleishman, James E. Herndon et al. · Journal of Clinical Oncology · 1994 · 106 citations

Bioavailability and pharmacokinetics of etoposide (VP-16).

Smyth Rd, M Pfeffer, Anthony J. Scalzo et al. · PubMed · 1985 · 86 citations

Factor V Leiden Mutation and Thromboembolism Risk in Women Receiving Adjuvant Tamoxifen for Breast Cancer

J. E. Garber, Susan Halabi, Sara M. Tolaney et al. · JNCI Journal of the National Cancer Institute · 2010 · 62 citations · Full text

Validation of Global Rating Scale and Checklist Instruments for the Infant Lumbar Puncture Procedure

James Gerard, David Kessler, Colleen Braun et al. · Simulation in Healthcare The Journal of the Society for Simulation in Healthcare · 2013 · 53 citations